JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Management of facial palsy after temporal bone fracture via the transmastoid approach.

CONCLUSION: The outcomes of extended subtotal facial nerve decompression via the transmastoid approach were good for facial palsy after temporal bone fracture (TBF). Surgical decompression should be carried out as soon as possible within 8 weeks after trauma.

OBJECTIVE: To present outcomes of facial palsy after TBF via the transmastoid approach and to describe our experience of management of facial palsy in TBF.

METHODS: A consecutive clinical series was reviewed retrospectively. Eighteen cases that underwent extended subtotal facial nerve decompression (decompression from the stylomastoid foramen to the labyrinthine segment) due to facial palsy after TBF involving the perigeniculate ganglion region were analyzed. The patients were operated between 2 and 14 weeks after trauma.

RESULTS: In all, 83.3% of the 18 cases recovered to normal or near-normal level (House-Brackmann (HB) grade I or II). Among the 12 cases operated within 8 weeks after trauma, 11 cases (91.7%) recovered to normal or near-normal level. In contrast, four of the six patients (66.7%) who were operated between 9 and 14 weeks after trauma recovered to HB grade I or II.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app